After analysis of data from 20 and 16 articles, respectively, 14.7% of meningiomas developed in female patients expressed estrogen receptors (95% CI: 5.9–23.5) compared with 7.5% of meningiomas developed in males (95% CI: 0.9–14.1). This evidence concerns the gene ESR1 and meningioma.